Anders Sönnerborg to Humans
This is a "connection" page, showing publications Anders Sönnerborg has written about Humans.
Connection Strength
0.123
-
[Future testing for SARS-CoV-2: not only more but smarter]. Lakartidningen. 2020 11 26; 117.
Score: 0.007
-
[Bats and humans]. Lakartidningen. 2020 04 29; 117.
Score: 0.007
-
A viral genome wide association study and genotypic resistance testing in patients failing first line antiretroviral therapy in the first large countrywide Ethiopian HIV cohort. BMC Infect Dis. 2019 Jul 01; 19(1):569.
Score: 0.007
-
Baseline predictors of antiretroviral treatment failure and lost to follow up in a multicenter countrywide HIV-1 cohort study in Ethiopia. PLoS One. 2018; 13(7):e0200505.
Score: 0.006
-
Pretreatment drug resistance in a large countrywide Ethiopian HIV-1C cohort: a comparison of Sanger and high-throughput sequencing. Sci Rep. 2018 05 15; 8(1):7556.
Score: 0.006
-
Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden. AIDS. 2018 04 24; 32(7):877-884.
Score: 0.006
-
Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes. AIDS. 2018 02 20; 32(4):469-476.
Score: 0.006
-
Prediction of coreceptor usage by five bioinformatics tools in a large Ethiopian HIV-1 subtype C cohort. PLoS One. 2017; 12(8):e0182384.
Score: 0.006
-
Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden. Sci Rep. 2017 07 25; 7(1):6371.
Score: 0.006
-
Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients. PLoS One. 2017; 12(7):e0180140.
Score: 0.006
-
Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy. PLoS One. 2017; 12(6):e0178942.
Score: 0.006
-
Assessing cervical intraepithelial neoplasia as an indicator disease for HIV in a low endemic setting: a population-based register study. BJOG. 2017 Oct; 124(11):1680-1687.
Score: 0.006
-
Monophylogenetic HIV-1C epidemic in Ethiopia is dominated by CCR5-tropic viruses-an analysis of a prospective country-wide cohort. BMC Infect Dis. 2017 01 06; 17(1):37.
Score: 0.006
-
Selection of drug-resistant HIV-1 during the early phase of viral decay is uncommon in treatment-naïve patients initiated on a three- or four-drug antiretroviral regimen including lamivudine. J Med Virol. 2009 Jan; 81(1):1-8.
Score: 0.003
-
Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents. Expert Opin Ther Pat. 2021 Apr; 31(4):339-350.
Score: 0.002
-
Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses. J Proteome Res. 2020 11 06; 19(11):4259-4274.
Score: 0.002
-
Infectivity of SARS-CoV-2: there Is Something More than D614G? J Neuroimmune Pharmacol. 2020 12; 15(4):574-577.
Score: 0.002
-
Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study. J Intern Med. 2021 03; 289(3):434-436.
Score: 0.002
-
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19. Cell. 2020 10 01; 183(1):158-168.e14.
Score: 0.002
-
Lakartidningen. 2020 03 23; 117.
Score: 0.002
-
MiDRMpol: A High-Throughput Multiplexed Amplicon Sequencing Workflow to Quantify HIV-1 Drug Resistance Mutations against Protease, Reverse Transcriptase, and Integrase Inhibitors. Viruses. 2019 08 30; 11(9).
Score: 0.002
-
Challenges in modelling the proportion of undiagnosed HIV infections in Sweden. Euro Surveill. 2019 Apr; 24(14).
Score: 0.002
-
Antiretroviral potency of 4'-ethnyl-2'-fluoro-2'-deoxyadenosine, tenofovir alafenamide and second-generation NNRTIs across diverse HIV-1 subtypes. J Antimicrob Chemother. 2018 10 01; 73(10):2721-2728.
Score: 0.002
-
Suppressive antiretroviral therapy associates with effective treatment of high-grade cervical intraepithelial neoplasia. AIDS. 2018 07 17; 32(11):1475-1484.
Score: 0.002
-
Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV disease. PLoS Pathog. 2018 04; 14(4):e1006973.
Score: 0.002
-
Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations. Int J Antimicrob Agents. 2018 May; 51(5):733-738.
Score: 0.002
-
Prophylaxis and treatment of HIV-1 infection in pregnancy - Swedish Recommendations 2017. Infect Dis (Lond). 2018 07; 50(7):495-506.
Score: 0.002
-
Human Immunodeficiency Virus Type-1 Elite Controllers Maintain Low Co-Expression of Inhibitory Receptors on CD4+ T Cells. Front Immunol. 2018; 9:19.
Score: 0.002
-
Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort. AIDS. 2018 Jan 14; 32(2):161-169.
Score: 0.002
-
PhyloGeoTool: interactively exploring large phylogenies in an epidemiological context. Bioinformatics. 2017 Dec 15; 33(24):3993-3995.
Score: 0.001
-
Transcriptomics and Targeted Proteomics Analysis to Gain Insights Into the Immune-control Mechanisms of HIV-1 Infected Elite Controllers. EBioMedicine. 2018 Jan; 27:40-50.
Score: 0.001
-
Indinavir in cerebrospinal fluid of HIV-1-infected patients. Lancet. 1997 Dec 20-27; 350(9094):1823.
Score: 0.001
-
Evaluating the Impact of Functional Genetic Variation on HIV-1 Control. J Infect Dis. 2017 11 27; 216(9):1063-1069.
Score: 0.001
-
Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers. Sci Rep. 2017 07 24; 7(1):6269.
Score: 0.001
-
A high rate of HIV-1 acquisition post immigration among migrants in Sweden determined by a CD4 T-cell decline trajectory model. HIV Med. 2017 10; 18(9):677-684.
Score: 0.001
-
Quantitative humoral profiling of the HIV-1 proteome in elite controllers and patients with very long-term efficient antiretroviral therapy. Sci Rep. 2017 04 06; 7(1):666.
Score: 0.001
-
Letter to the editor: Pre-exposure prophylaxis for HIV in Europe: The need for resistance surveillance. Euro Surveill. 2017 03 16; 22(11).
Score: 0.001
-
Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017 01 13; 7:40354.
Score: 0.001
-
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. BMC Infect Dis. 2014 Jul 21; 14:407.
Score: 0.001
-
Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment. Hepatology. 1995 Apr; 21(4):918-22.
Score: 0.000
-
Human immunodeficiency virus infection of the brain. II. Detection of intrathecally synthesized antibodies by enzyme linked immunosorbent assay and imprint immunofixation. J Neurol Sci. 1988 Oct; 87(1):37-48.
Score: 0.000